Literature DB >> 7951249

A frequent ala 4 to val superoxide dismutase-1 mutation is associated with a rapidly progressive familial amyotrophic lateral sclerosis.

D R Rosen1, A C Bowling, D Patterson, T B Usdin, P Sapp, E Mezey, D McKenna-Yasek, J O'Regan, Z Rahmani, R J Ferrante.   

Abstract

Familial amyotrophic lateral sclerosis (FALS), a degenerative disorder of motor neurons, is associated with mutations in the Cu/Zn superoxide dismutase gene SOD1 in some affected families. We confirm a recently reported ala4-->val mutation in exon 1 of the SOD1 gene and report that this mutation is both the most commonly detected of all SOD1 mutations and among the most clinically severe. By comparison with our other FALS families, the exon 1 mutation is associated with reduced survival time after onset: 1.2 years, as compared to 2.5 years for all other FALS patients. We also demonstrate that SOD1 is prominently expressed in normal motor neurons and that neural expression of SOD1 is not prevented by this exon 1 mutation. Assays of SOD1 enzymatic activity in extracts from red blood cells, lymphoblastoid cells, and brain tissues revealed an approximately 50% reduction in activity of cytosolic SOD1 in patients with this mutation compared to normal individuals. By contrast, patients with sporadic ALS had normal levels of SOD1 enzymatic activity. Why this SOD1 mutation causes motor neuron death in FALS remains to be established. While it may be that FALS is a consequence of loss of SOD1 function, it is also possible that motor neuron death in this dominantly inherited disease occurs because the mutations confer an additional, cytotoxic function on the SOD1 protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7951249     DOI: 10.1093/hmg/3.6.981

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  37 in total

1.  Evaluation of antioxidants, protein, and lipid oxidation products in blood from sporadic amyotrophic lateral sclerosis patients.

Authors:  P I Oteiza; O D Uchitel; F Carrasquedo; A L Dubrovski; J C Roma; C G Fraga
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

2.  A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide.

Authors:  M B Yim; J H Kang; H S Yim; H S Kwak; P B Chock; E R Stadtman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 3.  The roles of free radicals in amyotrophic lateral sclerosis.

Authors:  D Liu
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

Review 4.  The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

Authors:  Jason R Cannon; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

Review 5.  Cu/Zn superoxide dismutase gene mutations in amyotrophic lateral sclerosis: correlation between genotype and clinical features.

Authors:  A Radunovíc; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

6.  Pro-oxidant activity of Cu,Zn-superoxide dismutase.

Authors:  M B Yim; H S Yim; P Boon Chock; E R Stadtman
Journal:  Age (Omaha)       Date:  1998-04

7.  Enhanced free radical generation of FALS-associated Cu,Zn-SOD mutants.

Authors:  M B Yim; H S Yim; P B Chock; E R Stadtman
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

Review 8.  Superoxide dismutases: a physiopharmacological update.

Authors:  A Valdivia; S Pérez-Alvarez; J D Aroca-Aguilar; I Ikuta; J Jordán
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

9.  Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease.

Authors:  Mercedes Prudencio; P John Hart; David R Borchelt; Peter M Andersen
Journal:  Hum Mol Genet       Date:  2009-05-30       Impact factor: 6.150

10.  Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease.

Authors:  Manoj Kumar Jaiswal; Wolf-Dieter Zech; Miriam Goos; Christine Leutbecher; Alberto Ferri; Annette Zippelius; Maria Teresa Carrì; Roland Nau; Bernhard U Keller
Journal:  BMC Neurosci       Date:  2009-06-22       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.